UnknownPhase 2/3

Melatonin for Prevention of Post Stroke Delirium

Germany2,000 participantsStarted 2017-07-01

Plain-language summary

Post stroke delirium is prevalent in 10-30% of all stroke patients. We aimed to investigate wether Melatonin 2mg may prevent post stroke delirium.

Who can participate

Age range55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * all patients with stroke, TIA or ICH admitted to our stroke unit or intemdiate care unit * Stroke / ICH /TIA onset \<= 48h Exclusion Criteria: * RASS \<=4 * severe dementia, psychosis or depression

What they're measuring

Change of delir prevalence

Timeframe: 3months

Trial details

NCT IDNCT04122599

SponsorUniversity Hospital Tuebingen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-11-01

Contact for this trial

Annerose Mengel, MD

004970712985354 annerose.mengel@med.uni-tuebingen.de

View on ClinicalTrials.gov More Post Stroke Delirium trials